Education
About Us
Working with TipRanks
Follow Us
Marksans Pharma Limited (IN:MARKSANS)
:MARKSANS
MARKSANS Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹168.05 - ₹358.50
Previous CloseN/A
Volume681.00K
Average Volume (3M)95.37K
Market Cap
₹118.23B
Enterprise Value₹114.61B
Total Cash (Recent Filing)₹7.05B
Total Debt (Recent Filing)₹3.22B
Price to Earnings (P/E)31.1
Beta1.56
Next Earnings
Aug 07, 2025EPS EstimateN/A
Next Dividend Ex-Date
Aug 01, 2025Dividend Yield0.23%
Share Statistics
EPS (TTM)2.10
Shares Outstanding453,163,760
10 Day Avg. Volume71,478
30 Day Avg. Volume95,372
Financial Highlights & Ratios
PEG Ratio9.36
Price to Book (P/B)4.80
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Marksans Pharma Limited News
PremiumCompany Announcements
Marksans Pharma Appoints New Secretarial Auditor for Five-Year Term
PremiumCompany Announcements
Marksans Pharma to Engage Stakeholders at Upcoming ConferenceMARKSANS FAQ
What was Marksans Pharma Limited’s price range in the past 12 months?
Marksans Pharma Limited lowest stock price was ₹168.05 and its highest was ₹358.50 in the past 12 months.
What is Marksans Pharma Limited’s market cap?
Marksans Pharma Limited’s market cap is ₹118.23B.
When is Marksans Pharma Limited’s upcoming earnings report date?
Marksans Pharma Limited’s upcoming earnings report date is Aug 07, 2025 which is in 22 days.
How were Marksans Pharma Limited’s earnings last quarter?
Marksans Pharma Limited released its earnings results on May 19, 2025. The company reported ₹2.1 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.1.
Is Marksans Pharma Limited overvalued?
According to Wall Street analysts Marksans Pharma Limited’s price is currently Overvalued.
Does Marksans Pharma Limited pay dividends?
Marksans Pharma Limited pays a Annually dividend of ₹0.6 which represents an annual dividend yield of 0.23%. See more information on Marksans Pharma Limited dividends here
What is Marksans Pharma Limited’s EPS estimate?
Marksans Pharma Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Marksans Pharma Limited have?
Marksans Pharma Limited has 453,163,760 shares outstanding.
What happened to Marksans Pharma Limited’s price movement after its last earnings report?
Marksans Pharma Limited reported an EPS of ₹2.1 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.971%.
Which hedge fund is a major shareholder of Marksans Pharma Limited?
Currently, no hedge funds are holding shares in IN:MARKSANS
Company Description
Marksans Pharma Limited
Marksans Pharma Limited is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a wide range of generic pharmaceutical products. Headquartered in India, Marksans operates within the pharmaceutical and healthcare sectors, focusing on producing tablets, capsules, ointments, and other dosage forms. The company specializes in a diverse array of therapeutic segments, including pain management, cardiovascular, anti-diabetic, gastroenterology, and antibiotic medications.
Technical Analysis
Aurobindo Pharma Ltd
―
Dr. Reddy's Laboratories Ltd.
―
Glenmark Pharmaceuticals Limited
―
IPCA Laboratories Limited
―
Laurus Labs Ltd.
―